Delivery Order SPE2DB20D1004-SPE2DB23FF7J2

Award Date 4/24/23
Potential Completion Date 4/25/23
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,485.46 firm fixed-price contract is for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S, a respiratory medication. The contract has an ultimate completion date of November 18, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution services company. The delivery order is for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product, with a ceiling value of $9,344.68. The contract has an ultimate completion date of March 21, 2024 and was awarded on March 20, 2024. This delivery order falls...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $1,405.13 and has a period of performance through February 20, 2024. The contract provides the DLA with ANORO ELLIPTA 62.5-25 MCG inhalation medication in 60-count packages. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $3,748.82, is for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,374.48, is for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S, a medical product. The contract has a delivery period through February 27, 2025 and is a firm fixed-price type. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a $4,408.34 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the medical product "ANORO ELLIPTA 62.5-25 MCG INH 60S" and has an ultimate completion date of February 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S pharmaceutical product. The contract has a ceiling value of $3,548.87 and a completion date of July 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product. The award has a ceiling value of $1,577.43 and a completion date of August 20, 2024. The contract is a Firm Fixed Price arrangement. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S. The contract has a ceiling value of $3,309.25 and a period of performance through May 17, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product, with a ceiling value of $1,569.73 and a completion date of October 22, 2024. The contract is a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FF7J2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,169.02, is for the provision of ANORO ELLIPTA 62.5-25 MCG INH 60S, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery order does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:25 AM